In the News November 21, 2018

Law360 | FDA Finally Hitting Sweet Spot with Off-Label Oversight

Marc Scheineson comments on off-label oversight by the U.S. Food and Drug Administration.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.